Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study

Aims To examine the efficacy and safety of add‐on ipragliflozin in Japanese patients with type 2 diabetes in the early stage of insulin therapy. Methods Patients treated with insulin (bolus component

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2016-12, Vol.18 (12), p.1207-1216
Hauptverfasser:	Ishihara, Hisamitsu, Yamaguchi, Susumu, Nakao, Ikko, Okitsu, Akira, Asahina, Seitaro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adiponectin - metabolism Aged Asian Continental Ancestry Group Blood Glucose - metabolism Body Weight C-Peptide - metabolism Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Dipeptidyl-peptidase IV Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Double-Blind Method Double-blind studies DPP-4 inhibitor Drug Therapy, Combination Fasting Female Glucosides - therapeutic use Glycated Hemoglobin A - metabolism Hemoglobin Humans Hypoglycemia - chemically induced Hypoglycemic Agents - therapeutic use Insulin Insulin - therapeutic use insulin therapy Japan Male Middle Aged Original Reproductive Tract Infections - chemically induced SGLT2 inhibitor Thiophenes - therapeutic use Treatment Outcome type 2 diabetes Urinary Tract Infections - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!